BioNTech
$96.85Change from previous close: −1.48%Absolute change: −$1.45
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $24.33B
- Enterprise value
- $11.18B
- Forward P/E
- -17.4
- PEG
- 0.05
- Price/book
- 1.21
- Price/sales
- 9.18
- EV/EBITDA
- -8.10
- EV/revenue
- 4.22
Profitability and growth
- Gross margin
- 76.6%
- Operating margin
- -806.6%
- Net margin
- -63.6%
- ROE
- -9.3%
- ROA
- -5.4%
- Revenue growth (year over year)
- -59.5%
Financial health
- Total cash
- $13.46B
- Total debt
- $316.1M
- Debt/equity
- 0.02
- Current ratio
- 7.85
- Quick ratio
- 7.03
Dividends
- Payout ratio
- 0.0%
- Ex-dividend date
- June 2, 2022
Analysts and estimates
- Average price target
- $116.09
- Median price target
- $122.55
- High price target
- $139.95
- Low price target
- $73.36
- Analysts with a price target
- 20
- Consensus
- Buy
- Forward EPS
- -$5.56
- EPS estimate, current year
- -$4.65
Shares and trading
- Beta
- 1.29
- Average volume
- 1.15M
- Shares outstanding
- 251.2M
- Float
- 109M
- Institutional ownership
- 20.5%
- Insider ownership
- 57.3%
- Short interest (% of float)
- 3.5%
- Short ratio (days)
- 1.35